Alan J. Russell, Chief Scientific Officer at Edgewise Therapeutics, Inc. (EWTX), sold 86,756 shares at $18.84 ($1.5M) on 2021-11-03, disclosed to the SEC on 2021-11-03.
Open-market sale of $1.5M EWTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.02 | 469 | $8K | 0.5% |
| 2 | $17.43 | 17,519 | $305K | 19.7% |
| 3 | $17.43 | 17,519 | $305K | 19.7% |
| 4 | $17.98 | 20,822 | $374K | 24.2% |
| 5 | $17.98 | 20,822 | $374K | 24.2% |
| 6 | $18.84 | 4,243 |
| $80K |
| 5.2% |
| 7 | $18.84 | 4,243 | $80K | 5.2% |
| 8 | $19.42 | 1,119 | $22K | 1.4% |
| Total | $17.86 avg | 86,756 | $1.5M | 100% |
| Filing → |
| EWTX | SELL | 2025-11-13 | $2.1M | — | Filing → |
| EWTX | SELL | 2025-08-28 | $1.5M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $26K | — | Filing → |